Caley Castelein Talaris Therapeutics, Inc. (TALS) insider trading activity

TALS Quotes by TradingView

Caley Castelein is Director of Talaris Therapeutics, Inc.. Currently has a direct ownership of 516,519 shares of TALS, which is worth approximately $1.4 Million. The most recent transaction as insider was on Oct 27, 2023, when has been sold 15,800 shares (Common Stock) at a price of $14.55 per share, resulting in proceeds of $229,890. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 517K
0% 3M change
n/a 12M change
Total Value Held $1.4 Million

Caley Castelein Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 27 2023
BUY
Open market or private purchase
$229,890 $14.55 p/Share
15,800 Added 2.97%
516,519 Common Stock
Oct 25 2023
BUY
Open market or private purchase
$50,694 $12.07 p/Share
4,200 Added 0.83%
500,719 Common Stock
Oct 19 2023
BUY
Grant, award, or other acquisition
-
496,519 Added 50.0%
496,519 Common Stock

Also insider at

VRAY
ViewRay, Inc. Healthcare
Director
AADI
Aadi Bioscience, Inc. Healthcare
CC

Caley Castelein

Director
Pacific Palisades, CA

Track Institutional and Insider Activities on TALS

Follow Talaris Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TALS shares.

Notify only if

Insider Trading

Get notified when an Talaris Therapeutics, Inc. insider buys or sells TALS shares.

Notify only if

News

Receive news related to Talaris Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TALS